Indite Blogs Articles

It appears the drug Topamax, marketed by Ortho-McNeil Pharmaceuticals, is facing some severe problems with FDA of U.S.A. Topamax is often a common drug for controlling epileptic seizures and is also marketed by this subsidiary organization of Johnson & Johnson. Recently it has come to the notice of FDA that one of its side effects observed in clinical trial with animals where animals gave birth to babies with cleft lip problem is occurring with humans too and in a higher percentage. The percentage of women having this problem is slightly larger in the case of humans whereas the percentage was negligible in the case of animals during clinical trials. FDA wants this fact to be put in the literature and label of the drug so that women will be aware of this problem and avoid pregnancy when they are under this medication. If the manufacturers agree to FDA mandate, then it is certain that they will lay themselves open to a litany of topamax lawsuits. Many topamax lawyers are sensing a good opportunity here and have announced through web sites that they are ready to file the cases of mothers who might have had topamax cleft lip during their pregnancy and experienced this problem with their children. They feel that with the past history of this Johnson & Johnson subsidiary they are onto a good case if they can find some of these mothers who might have been affected. Only last year, the Ortho-McNeil Pharmaceuticals was slapped with a criminal fine for marketing this drug through a Doctor For A Day Program where it was suggested that psychiatric patients can be given this drug. As the company had not legally cleared this use with the FDA, they were made to pay a criminal fine of $ 6.14 million. So this year, the firm is really a sitting duck for topamax lawyers if only they can get hold of some cases where children with topamax birth defects have been born to women who have been taking this drug for control of epileptic attacks.